This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: The University of Tennessee Research Foundation. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Jiyun Chen: Innovator in Selective Androgen Receptor Modulators
Introduction
Jiyun Chen is a prominent inventor based in Columbus, OH (US). She has made significant contributions to the field of selective androgen receptor modulators, with a focus on developing innovative solutions for hormone-related conditions. With a total of 2 patents, her work is paving the way for advancements in medical treatments.
Latest Patents
Jiyun Chen's latest patents include groundbreaking inventions related to multi-substituted selective androgen receptor modulators and methods of use thereof. These inventions provide a class of androgen receptor targeting agents (ARTA) that define a new subclass of compounds known as selective androgen receptor modulators (SARM). Several of these SARM compounds exhibit unexpected androgenic and anabolic activity as nonsteroidal ligands for the androgen receptor. Additionally, some compounds demonstrate antiandrogenic activity. The applications of these SARM compounds are extensive, including male contraception, treatment of hormone-related conditions in both males and females, and prevention of muscular wasting conditions.
Career Highlights
Jiyun Chen is affiliated with the University of Tennessee Research Foundation, where she continues to innovate and contribute to research in her field. Her work has garnered attention for its potential to address various health issues related to hormone decline and other conditions.
Collaborations
Some of her notable coworkers include James T Dalton and Duane Douglas Miller, who collaborate with her on various research projects.
Conclusion
Jiyun Chen's contributions to the field of selective androgen receptor modulators highlight her role as an influential inventor. Her innovative patents are set to make a significant impact on the treatment of hormone-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
